Direct Biologics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Direct Biologics

Access the complete profile.

Direct Biologics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	339112 Surgical & Medical Instrument Manufacturing
Address	5301 Southwest Parkway Uplands Bldg 1, Suite 415 Austin, TX 78735

Note: Revenues for privately held companies are statistical evaluations.


Direct Biologics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Direct Biologics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Direct Biologics is classified as operating in the Surgical & Medical Instrument Manufacturing industry, NAICS Code 339112.

Direct Biologics Annual Revenue and Growth Rate

Direct Biologics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Direct Biologics's revenues are gauged from an analysis of company filings.

Direct Biologics's Income Statement (based on Industry Averages)

Direct Biologics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Direct Biologics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
December 13, 2022	116	N/A	$0 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Direct Biologics is developing and marketing. Direct Biologics doesn't have any recent trademark applications, indicating Direct Biologics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
OSTEOZOMES Medical products and therapeutic applications for regenerative medicine, cosmetics, and tissue regeneration, namely, human allograft tissue in the form of amniotic patches, amniotic fluid, and purified exosomes, all for the regenerative treatment of wounds, burns, and soft tissue injuries	08/29/2022
EXOSOME EXPERTS Medical products and therapeutic applications for regenerative medicine, cosmetics, and tissue regeneration, namely, human allograft tissue in the form of amniotic patches, amniotic fluid, and purified exosomes, all for the regenerative treatment of wounds, burns, and soft tissue injuries	08/29/2022
NATURAL INTELLIGENCE Medical products for tissue repair and regeneration, namely, extracellular vesicle isolate products (EVIPs)	01/17/2022

See all trademarks and details in the Full Report.

Market Share of Direct Biologics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Direct Biologics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
EMBECTA	Parsippany, NJ	100
STRUCTURE MEDICAL	Mooresville, NC	34
AUTOCAM MEDICAL DEVICES	Kentwood, MI	30
SCHARNBERG HOLDING	Des Moines, IA	26
SPECIALTY SURGICAL INSTRUMENTATION	Antioch, TN	24
MIDWEST INTERVENTIONAL SYSTEMS	Maple Grove, MN	19
VITA NEEDLE	Needham, MA	17
PYLANT MEDICAL	Grapevine, TX	17
MEDTEC	Orange City, IA	16

Nearby Competitors

These companies are similar in business line and location to Direct Biologics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
APOLLO ENDOSURGERY US	Austin, TX	100
ORIGEN BIOMEDICAL	Austin, TX	69
BAYLIS MEDICAL USA	Austin, TX	44
INTERNATIONAL BIOMEDICAL	Austin, TX	42
MICROTRANSPONDER	Austin, TX	36
OSTEOCENTRIC TECHNOLOGIES	Austin, TX	33

Other Companies at 5301 Southwest Parkway, Austin TX

Company	Headquarters	Revenue ($ MM)
CATAPULT SYSTEMS	Austin, TX	100
TRICENTIS USA	Austin, TX	80
INVOICED	Austin, TX	1

Future Competition: Direct Biologics's Fastest Growing Competitors

These companies are in the same general field as Direct Biologics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)